Login Register Cart 0
Generic placeholder image

Current Nanomaterials

Editor-in-Chief

ISSN (Print): 2405-4615
ISSN (Online): 2405-4623

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Formulation of Methotrexate Loaded Solid Lipid Nanoparticles By Micro Emulsion Technique

Author(s): Abbaraju Krishnasailaja and Ayesha Siddiqua Gazi

Volume 8, Issue 2, 2023

Published on: 05 July, 2022

Page: [153 - 161] Pages: 9

DOI: 10.2174/2405461507666220428121823

Price: $65

conference banner
Abstract

Aim: The aim of this study was to develop and characterize Methotrexate loaded solid lipid nanoparticles by Microemulsion technique.

Background: Methotrexate is a preferable anti metabolite drug. It is used in the treatment of certain cancers like breast cancer, skin and lung cancer. Clinical studies have revealed that the curative effect of MTX tablet on cancers was limited due to their toxic dose-related side effects to normal cells, nephrotoxicity, and bone marrow suppression, acute and chronic hepatotoxicity and also due to the drug resistance of the tumour cells. Hence, there is a need to develop methotrexate solid lipid nanoparticles in order to minimize the adverse effects associated with the MTX tablet dosage form.

Objectives: The objective of the research work is to formulate, characterize and evaluate Methotrexate solid lipid nanoparticles by micro emulsification solidification technique.

Methods: Solid lipid nanoparticles are prepared by using lipids stearic acid and glycerol monostearate by varying the concentration of surfactant. Three formulations were prepared with each lipid. Micro emulsion technique was adopted for the preparation of solid lipid nanoparticles. Each formulation was evaluated for drug content, entrapment efficiency, loading capacity and in vitro drug release studies. Both the lipids were compared for the characterization and evaluation parameters.

Results: On comparison Glycerol monostearate was found to be a better lipid over Stearic acid for the preparation of Methotrexate solid lipid nanoparticles because of its smaller mean particle diameter (238.8 nm), higher stability (-56.5 mV) and greater entrapment efficiency.

Conclusion: Methotrexate solid lipid nanoparticles were successfully prepared with higher stability and drug release rate.

Keywords: Stearic acid (SA), glycerol monostearte (GMS), methotrexate (MTX), solid lipid nanoparticles SLN’s, drug release rate, micro emulsion technique.

« Previous Next »
Graphical Abstract

[1]
Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep 2012; 64(5): 1020-37.
[http://dx.doi.org/10.1016/S1734-1140(12)70901-5] [PMID: 23238461]
[2]
Tamizhrasi S, Shukla A, Shivkumar T, Rathi V, Rathi JC. Formulation and evaluation of lamivudine loaded polymethacrylic acid nanoparticles. Int J Pharm Tech Res 2009; 1(3): 411-5.
[3]
De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomedicine 2008; 3(2): 133-49.
[http://dx.doi.org/10.2147/IJN.S596] [PMID: 18686775]
[4]
Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J Pharm Sci 2009; 71(4): 349-58.
[http://dx.doi.org/10.4103/0250-474X.57282] [PMID: 20502539]
[5]
Jawahar N, Meyyanathan SN. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review. Int J Health Allied Sci 2012; 1: 217-23.
[http://dx.doi.org/10.4103/2278-344X.107832]
[6]
Nagavarma BV, Yadav HK, Ayaz AV, Vasudha LS, Shivakumar HG. Different techniques for preparation of Polymeric nanoparticles- A review. Asian J Pharm Clin Res 2012; 5(3): 16-23.
[7]
Vyas SP, Khar RK. Targeted & controlled drug delivery Novel carrier systems CBS publication 2002; 331-87.
[8]
Jain NK. Advances in controlled and novel drug delivery CBS Publisher & Distributers 2001. 408
[9]
Desai D, Shah D. Implication of nanoparticles for controlled drug delivery system. IJPSR 2013; 3(6): 1125-33.
[10]
Kumari SD, Tharani CB, Narayanan N, Kumar CS. Formulation and characterization of methotrexate loaded sodium alginate chitosan nanoparticles. Indian J Res Pharm Biotechnol 2013; 1(6): 915-21.
[11]
Taheri A, Dinarvand R, Atyabi F, et al. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide. Int J Mol Sci 2011; 12(7): 4591-608.
[http://dx.doi.org/10.3390/ijms12074591] [PMID: 21845098]
[12]
Ji J, Wu D, Liu L, Chen J, Xu Y. Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery. Polym Bull 2011; 68: 1707-20.
[13]
Seo DH, Jeong YI, Kim DG, Jang MJ, Jang MK, Nah JW. Methotrexate-incorporated polymeric nanoparticles of methoxy poly (ethylene glycol)-grafted chitosan. Int J Sci 2008; 17(7): 538-43.
[14]
Ruckmani K, Sivakumar M, Ganeshkumar PA. Methotrexate loaded Solid Lipid Nanoparticles (SLN) for effective treatment. J Nanosci Nanotechnol 2006; 6: 1-5.
[15]
Misra R, Mohanty S. Sustained release of methotrexate through liquid-crystalline folate nanoparticles. J Mater Sci Mater Med 2014; 25(9): 2095-109.
[16]
Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010; 385(1-2): 113-42.
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.018] [PMID: 19825408]
[17]
Garg A, et al. Formulation, characterization and application on nanoparticle: A review. Pharm Sin 2011; 2(2): 17-26.
[18]
Krishna RSM, Shiva Kumar HG, Gowda DV, Banerjee S. Nanoparticles: A novel drug delivery system. Indian J Pharm Edu Res 2006; 40(1): 15-21.
[19]
Magneheim B, Benita S. Nanoparticle’s characterization: A comprehensive physicochemical approach. STP Pharmaceutical Science 1991; 1: 221-41.
[20]
Kreuter J. Nanoparticles Colloidal drug delivery systems New York:; Marcel Dekker:. 1994; pp. 219-342.
[21]
Chakraborty C, Pal S, Doss GP, Wen Z-hi-Hong. Lin Chan-Shing. Nanoparticles as smart pharmaceutical delivery. Front Biosci 2013; 18: 1030-50.
[http://dx.doi.org/10.2741/4161]
[22]
Garg A, Visht S, Sharma PK, Kumar N. Formulation, characterisation and application on nanoparticle: A review. Pharm Sin 2011; 2(2): 17-26.
[23]
Vollrath A, Schubert S, Windhab N, Biskup C, Schubert US. Labeled nanoparticles based on pharmaceutical eudrAGIT® S 100 polymers. Macromol Rapid Commun 2010; 31(23): 2053-8.
[http://dx.doi.org/10.1002/marc.201000373] [PMID: 21567630]
[24]
Tripathi SL, Rana K, Rathore V, Kumar A. Development andoptimization of ranitidine hydrochloride nanospheres by 3 2 factorial design. Int J Pharm Prof Res 2013; 4(4): 928-32.
[25]
Nepolean R, Narayanan N, Subramaniyan N, Venkateswaran K, Vinoth J. Colon targeted methacrylic acid copolyeric nanoparticles for improved oral bioavailability of nisoldipine. Int J Biol Pharm Res 2012; 3(8): 962-7.
[26]
Khalid Md. Development of diosmin loaded eudragit s100 polymeric nanoparticles: An investigation of anti-oxidant effect. Int J Biol Pharm Allied Sci 2014; 3(8): 2015-26.
[27]
Kshirsagar SJ. Nanoparticle for colon specific drug delivery system. J Nanomed Nanotechnol 2013; 4(6): 257-90.
[28]
Gaikwad A, Tamzhrasi S, Sorti A, Gavali P, Mehare G. Formulation and in vitro characterization frusemide of polymethacrylic acid nanoparticles containing frusemide. Int J Pharm Tech Res 2010; 2(1): 301-4.

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy